LeaskG.ParkerD. (2004) ‘An application of strategic group theory to the UK pharmaceuticals industry’, European Business Journal, 16(1), 1–10.
2.
GwynneP. (2004) ‘IBM makes its move into medical R&D’, Research Technology Management, Jan/Feb, 47(1), 4–5.
3.
PorterM.E.TeisbergE.O. (2004) ‘Redefining healthcare competition’, Harvard Business Review, 82(6), 64–78.
4.
LangleyP.C. (2004) ‘The NICE reference case requirement: implications for drug manufacturers and health systems’, PharmacoEconomics, 22(4), 267–272.
5.
SaltzmanC. (2004) ‘Issues behind the new medicaid legislation’, Journal of Financial Service Professionals, 58(2), 13–16.
6.
LichtenthalerE. (2004) ‘Coordination of technology intelligence processes: a study in technology intensive multinationals’, Technology Analysis & Strategic Management, 16(2), 197–202.
7.
LiljegrenE. (2004) ‘Cognitive engineering methods as usability evaluation tools for medical equipment’, International Journal of Industrial Ergonomics34(1), 49–63.
